Service center for formulation, clinical and commercial manufacturing

Our facilities in Tampa (FL) US are an integral component of our design, development and manufacturing network for drug substances and specialized drug products. Working collaboratively with our customers, our team designs, develops and manufactures tablets and encapsulated formulations for immediate and modified release applications. The site provides a full range of services from preformulation and formulation development through clinical and commercial scale production of specialized drug products, inclusive of analytical method development and packaging and logistics services for clinical supplies.

Tampa also serves as our US Center of Excellence for rapid first-in-human services utilizing Powder-in-Capsule (PIC) based on our proprietary Xcelodose® Precision Powder Micro-Dosing Technology. We have Xcelodose® capacity in place for non-cGMP development studies and cGMP clinical manufacturing. Larger scale encapsulation (Harro Hoefliger Modu C) processing is also in place to ensure accelerated pathway to commercialization where required.

Meet the expert

“Tampa is the center of excellence for all Powder in Capsule needs using the Xcelodose® system; spanning from development to manufacturing.”

Mark Cappucci serves as the Preformulation Team Lead at Lonza’s site in Tampa, Florida, USA. He has more than 23 years of experience in the pharmaceutical industry, with expertise in areas including drug substance characterization, polymorph identification, and microdosing techniques using Lonza’s Xcelodose® system. Mark joined Lonza in 2004, after working for Amgen and Bausch & Lomb in positions of increasing authority. He received his B.S. in Chemistry from The Ohio State University.